* Review of Chronic Lymphocytic Leukemia (CLL), in the Context of COVID-19 & Its Variants

* Significant Role of Testing in Informing Your Treatment Choices

* First Line Treatment Options

* Treatment of Relapsed & Refractory CLL

* Re-Testing Importance in Determining Treatment for 2nd & 3rd Line Treatments

* Current Perspectives on New & Emerging Treatments of CLL

* Updates on Clinical Trials & Their Significance for CLL

* Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions, Follow-Up Appointments & Discussion of OpenNotes

* Practical Support to Cope with CLL

* Questions for Our Panel of Experts